4//SEC Filing
Guenther Sven 4
Accession 0001437749-19-023646
CIK 0001434647other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:15 PM ET
Size
5.6 KB
Accession
0001437749-19-023646
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Guenther Sven
Exec VP R&D
Transactions
- Award
Stock Option (right to buy)
2019-11-25+56,000→ 56,000 totalExercise: $0.52Exp: 2029-11-24→ Common Stock (56,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 100% of the shares underlying the option will vest upon the acceptance of a new drug application for the Company's product candidate, KP415, by the U.S. Food and Drug Administration, provided that at the relevant vesting date such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
Documents
Issuer
KEMPHARM, INC
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001638368
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 4:15 PM ET
- Size
- 5.6 KB